Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	actin filament-based process	FLNC PHACTR2 ANK2 CARMIL1 INPPL1 SH3BP1 PSTPIP2 BCAR1 ECT2 TCAP CCDC88C CRACD GAS2L1 LDB3 SLC9A1 SSH1 ARHGEF10 SIPA1L1 CACNA1H CLDN19 EPB41L1	4.42e-06	912	154	21	GO:0030029
GeneOntologyBiologicalProcess	actin cytoskeleton organization	FLNC PHACTR2 CARMIL1 INPPL1 SH3BP1 PSTPIP2 BCAR1 ECT2 TCAP CRACD GAS2L1 LDB3 SLC9A1 SSH1 ARHGEF10 SIPA1L1 CLDN19 EPB41L1	3.21e-05	803	154	18	GO:0030036
Domain	Post-SET_dom	KMT2B NSD1 SETD2 KMT2D	7.11e-06	16	152	4	IPR003616
Domain	PostSET	KMT2B NSD1 SETD2 KMT2D	7.11e-06	16	152	4	SM00508
Domain	POST_SET	KMT2B NSD1 SETD2 KMT2D	7.11e-06	16	152	4	PS50868
Domain	Paralemmin	PALMD PALM	6.58e-05	2	152	2	IPR004965
Domain	Cezanne-2	OTUD7B OTUD7A	6.58e-05	2	152	2	IPR033477
Domain	Paralemmin	PALMD PALM	6.58e-05	2	152	2	PF03285
Domain	NHE_CaM-bd	SLC9A1 SLC9A2	1.96e-04	3	152	2	IPR032103
Domain	VDCC_T_a1	CACNA1I CACNA1H	1.96e-04	3	152	2	IPR005445
Domain	NEXCaM_BD	SLC9A1 SLC9A2	1.96e-04	3	152	2	PF16644
Domain	SET	KMT2B NSD1 SETD2 KMT2D	3.38e-04	41	152	4	PF00856
Domain	Znf_PHD-finger	KMT2B PHRF1 NSD1 FBXL19 KMT2D	4.64e-04	79	152	5	IPR019787
Domain	BAR	ACAP1 AMPH SH3BP1	4.65e-04	19	152	3	PS51021
Domain	SET	KMT2B NSD1 SETD2 KMT2D	5.27e-04	46	152	4	SM00317
Domain	FYrich_C	KMT2B KMT2D	6.47e-04	5	152	2	IPR003889
Domain	FYrich_N	KMT2B KMT2D	6.47e-04	5	152	2	IPR003888
Domain	AWS	NSD1 SETD2	6.47e-04	5	152	2	SM00570
Domain	FYRC	KMT2B KMT2D	6.47e-04	5	152	2	SM00542
Domain	FYRN	KMT2B KMT2D	6.47e-04	5	152	2	SM00541
Domain	AWS	NSD1 SETD2	6.47e-04	5	152	2	PS51215
Domain	AWS_dom	NSD1 SETD2	6.47e-04	5	152	2	IPR006560
Domain	FYRN	KMT2B KMT2D	6.47e-04	5	152	2	PF05964
Domain	FYRC	KMT2B KMT2D	6.47e-04	5	152	2	PF05965
Domain	FYRC	KMT2B KMT2D	6.47e-04	5	152	2	PS51543
Domain	FYRN	KMT2B KMT2D	6.47e-04	5	152	2	PS51542
Domain	SET_dom	KMT2B NSD1 SETD2 KMT2D	7.26e-04	50	152	4	IPR001214
Domain	SET	KMT2B NSD1 SETD2 KMT2D	7.26e-04	50	152	4	PS50280
Domain	PHD	KMT2B PHRF1 NSD1 FBXL19 KMT2D	8.01e-04	89	152	5	SM00249
Domain	Znf_PHD	KMT2B PHRF1 NSD1 FBXL19 KMT2D	8.86e-04	91	152	5	IPR001965
Domain	ZF_PHD_2	KMT2B PHRF1 NSD1 FBXL19 KMT2D	1.08e-03	95	152	5	PS50016
Domain	ZF_PHD_1	KMT2B PHRF1 NSD1 FBXL19 KMT2D	1.13e-03	96	152	5	PS01359
Domain	ZF_A20	OTUD7B OTUD7A	1.35e-03	7	152	2	PS51036
Domain	zf-A20	OTUD7B OTUD7A	1.35e-03	7	152	2	PF01754
Domain	Znf_A20	OTUD7B OTUD7A	1.35e-03	7	152	2	IPR002653
Domain	Ski_Sno	DACH1 SKI	1.35e-03	7	152	2	PF02437
Domain	-	DACH1 SKI	1.35e-03	7	152	2	3.10.260.20
Domain	Transform_Ski	DACH1 SKI	1.35e-03	7	152	2	IPR003380
Domain	ZnF_A20	OTUD7B OTUD7A	1.35e-03	7	152	2	SM00259
Domain	AH/BAR-dom	ACAP1 AMPH SH3BP1	1.83e-03	30	152	3	IPR027267
Domain	-	ACAP1 AMPH SH3BP1	1.83e-03	30	152	3	1.20.1270.60
Domain	NaH_exchanger	SLC9A1 SLC9A2	2.28e-03	9	152	2	IPR004709
Domain	Ank	ACAP1 ANKS6 ANK2 RIPK4 ANKRD30A ANKRD33B NOTCH2	2.67e-03	228	152	7	PF00023
Domain	IG_FLMN	FLNC TRIM3	2.84e-03	10	152	2	SM00557
Domain	VDCCAlpha1	CACNA1I CACNA1H	2.84e-03	10	152	2	IPR002077
Domain	PHD	KMT2B PHRF1 NSD1 KMT2D	3.27e-03	75	152	4	PF00628
Domain	TF_DNA-bd	NRL FOSL2 ATF6B	3.35e-03	37	152	3	IPR008917
Domain	Filamin	FLNC TRIM3	3.45e-03	11	152	2	PF00630
Domain	ZF_CXXC	KMT2B FBXL19	3.45e-03	11	152	2	PS51058
Domain	BAH	BAHD1 TNRC18	3.45e-03	11	152	2	PS51038
Domain	FILAMIN_REPEAT	FLNC TRIM3	3.45e-03	11	152	2	PS50194
Domain	Filamin/ABP280_rpt	FLNC TRIM3	3.45e-03	11	152	2	IPR001298
Domain	Filamin/ABP280_repeat-like	FLNC TRIM3	3.45e-03	11	152	2	IPR017868
Domain	BAH_dom	BAHD1 TNRC18	3.45e-03	11	152	2	IPR001025
Domain	DNA-bd_dom_put	DACH1 SKI	3.45e-03	11	152	2	IPR009061
Domain	BAH	BAHD1 TNRC18	3.45e-03	11	152	2	SM00439
Domain	Znf_CXXC	KMT2B FBXL19	3.45e-03	11	152	2	IPR002857
Domain	BAH	BAHD1 TNRC18	3.45e-03	11	152	2	PF01426
Domain	zf-CXXC	KMT2B FBXL19	3.45e-03	11	152	2	PF02008
Domain	Cation/H_exchanger_CPA1	SLC9A1 SLC9A2	3.45e-03	11	152	2	IPR018422
Domain	GDS_CDC24_CS	ECT2 ARHGEF10 VAV2	3.90e-03	39	152	3	IPR001331
Domain	PP2C_BS	PPM1D ILKAP	4.12e-03	12	152	2	IPR000222
Domain	Laminin_G_2	LAMA3 COL5A3 CELSR3	4.19e-03	40	152	3	PF02210
Domain	ANK	ACAP1 ANKS6 ANK2 RIPK4 ANKRD30A ANKRD33B NOTCH2	4.53e-03	251	152	7	SM00248
Domain	ANK_REPEAT	ACAP1 ANKS6 ANK2 RIPK4 ANKRD30A ANKRD33B NOTCH2	4.73e-03	253	152	7	PS50088
Domain	ANK_REP_REGION	ACAP1 ANKS6 ANK2 RIPK4 ANKRD30A ANKRD33B NOTCH2	4.83e-03	254	152	7	PS50297
Domain	OTU	OTUD7B OTUD7A	4.84e-03	13	152	2	PF02338
Domain	SH3_2	AMPH MAP3K9 VAV2 ARHGAP33	5.34e-03	86	152	4	PF07653
Domain	SH3_2	AMPH MAP3K9 VAV2 ARHGAP33	5.34e-03	86	152	4	IPR011511
Domain	LamG	LAMA3 COL5A3 CELSR3	5.48e-03	44	152	3	SM00282
Domain	Na_H_Exchanger	SLC9A1 SLC9A2	5.62e-03	14	152	2	PF00999
Domain	Cation/H_exchanger	SLC9A1 SLC9A2	5.62e-03	14	152	2	IPR006153
Domain	Ankyrin_rpt	ACAP1 ANKS6 ANK2 RIPK4 ANKRD30A ANKRD33B NOTCH2	5.70e-03	262	152	7	IPR002110
Domain	PDZ	ARHGAP23 LDB3 SIPA1L1 MAST1 PDZD2	5.96e-03	141	152	5	PF00595
Domain	OTU	OTUD7B OTUD7A	6.44e-03	15	152	2	PS50802
Domain	BAR	AMPH SH3BP1	6.44e-03	15	152	2	SM00721
Domain	BAR	AMPH SH3BP1	6.44e-03	15	152	2	PF03114
Domain	PPM_1	PPM1D ILKAP	6.44e-03	15	152	2	PS01032
Domain	OTU_dom	OTUD7B OTUD7A	6.44e-03	15	152	2	IPR003323
Domain	WW	SETD2 PLEKHA5 DGCR8	6.59e-03	47	152	3	PF00397
Domain	ZnF_C3H1	ZC3H14 ZC3H18 ZC3H11A	6.99e-03	48	152	3	SM00356
Domain	WW	SETD2 PLEKHA5 DGCR8	6.99e-03	48	152	3	SM00456
Domain	Znf_FYVE_PHD	KMT2B PHRF1 NSD1 FBXL19 KMT2D	7.08e-03	147	152	5	IPR011011
Domain	PDZ	ARHGAP23 LDB3 SIPA1L1 MAST1 PDZD2	7.28e-03	148	152	5	SM00228
Domain	BAR_dom	AMPH SH3BP1	7.33e-03	16	152	2	IPR004148
Domain	-	ARHGAP23 LDB3 SIPA1L1 MAST1 PDZD2	7.70e-03	150	152	5	2.30.42.10
Domain	PH	ACAP1 ARHGAP23 TEX2 ECT2 AFAP1L2 PLEKHA5 VAV2	7.80e-03	278	152	7	SM00233
Domain	PDZ	ARHGAP23 LDB3 SIPA1L1 MAST1 PDZD2	7.91e-03	151	152	5	PS50106
Domain	PH_domain	ACAP1 ARHGAP23 TEX2 ECT2 AFAP1L2 PLEKHA5 VAV2	8.09e-03	280	152	7	IPR001849
Domain	PDZ	ARHGAP23 LDB3 SIPA1L1 MAST1 PDZD2	8.13e-03	152	152	5	IPR001478
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ZXDC RNF223 FLNC CRYBG2 ANKS6 KMT2B SPEG FOSL2 INPPL1 NSD1 PFAS CC2D1A SFI1 FBXL19 KDM6B TTC3 DENND1A BAHD1 TBC1D17 GGT7 CCDC88C GAS2L1 SCAF1 NCOR1 TNRC18 ZC3H11A KMT2D CELSR3 PTPRF SSH1 CTDP1 PALM CACNA1H DMWD ANKRD33B NOTCH2 ARHGAP33	1.40e-21	1105	160	37	35748872
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	KMT2B C9orf78 FOSL2 CARMIL1 PHRF1 ZC3H18 GPRIN1 THOC2 CTTNBP2NL OTUD7B SCAF1 NCOR1 SETD2 ZC3H11A KMT2D SSH1 SIPA1L1 CTDP1 AFF1 DMWD SRRM2 NOTCH2	1.11e-11	774	160	22	15302935
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PHACTR2 TEX2 CARMIL1 INPPL1 CC2D1A BCAR1 NCKAP5L ECT2 DENND1A CCDC88C CEP89 ARHGEF10 SIPA1L1 OTUD7A MAP3K9 PLEKHA5 SRRM2 EPB41L1 NOTCH2	1.92e-08	861	160	19	36931259
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PPM1D PFAS PSTPIP2 BCAR1 GPRIN1 NCKAP5L PHKA1 NCOR1 KMT2D PPP2R5B PPP3CB PTPRF SSH1 CEP89 PPP1R37 PALM DMWD SRRM2 EPB41L1 ILKAP	8.66e-08	1049	160	20	27880917
Pubmed	Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins.	FLNC TCAP LDB3 PPP3CB	1.39e-07	11	160	4	11842093
Pubmed	Genome-wide YFP fluorescence complementation screen identifies new regulators for telomere signaling in human cells.	NUDT18 AMPH C9orf78 SH3BP1 ZC3H18 JSRP1 GAS2L1 AFAP1L2 PALM REM2 EPB41L1	4.20e-07	330	160	11	21044950
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	KMT2B PFAS KDM6B ARHGEF10 SRRM2 EPB41L1 PDZD2	5.59e-07	104	160	7	9205841
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	TNIP1 CC2D1A BCAR1 THOC2 ECT2 CTTNBP2NL NCOR1 ZC3H11A CTDP1 PLEKHA5 SRRM2 EPB41L1 ZNF574	6.61e-07	503	160	13	16964243
Pubmed	Functional proteomics mapping of a human signaling pathway.	FLNC KMT2B IRF2BP1 BCCIP TNIP1 SKI TTC3 NCOR1 KMT2D PTPRF PPP1R37 AFF1 ZNF76 NOTCH2	6.83e-07	591	160	14	15231748
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	IRF2BP1 CARMIL1 INPPL1 PALMD GAS2L1 PLEKHA5 SRRM2	7.22e-07	108	160	7	19531213
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SEMA4D KCNH8 FOSL2 CARMIL1 LAMA3 BCAR1 RBBP8NL SKI TTC3 DENND1A TNRC18 ZC3H11A LRFN2 KNDC1 PRKAR1B MAST1 AFF1 CACNA1H VAV2 EPB41L1 NOTCH2 PDZD2	1.43e-06	1489	160	22	28611215
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ZC3H14 KMT2B DACH1 NSD1 TNIP1 CC2D1A GPRIN1 THOC2 NCOR1 SETD2 ZC3H11A KMT2D PLEKHA5	1.74e-06	549	160	13	38280479
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	IRF2BP1 NCKAP5L NCOR1 KRBA1 ZC3H11A KMT2D SIPA1L1 NOTCH2	2.37e-06	184	160	8	32908313
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ANK2 PRR36 NHSL2 SH3BP1 NSD1 TTC3 RTN1 ATF6B TRIM3 CCDC88C NCOR1 PPP3CB SSH1 SIPA1L1 PRKAR1B PLEKHA5 EPB41L1	2.43e-06	963	160	17	28671696
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	FLNC ACAP1 PHACTR2 KMT2B ANK2 PANX2 BCAR1 THOC2 ECT2 CELSR3	3.25e-06	329	160	10	17474147
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	PHACTR2 CARMIL1 INPPL1 GPRIN1 CEP89 ARHGEF10 PPP1R37 PALM PLEKHA5 EPB41L1 NOTCH2	4.44e-06	421	160	11	36976175
Pubmed	DACH1 inhibits transforming growth factor-beta signaling through binding Smad4.	DACH1 SKI NCOR1	5.26e-06	8	160	3	14525983
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TEX2 INPPL1 PFAS RTN1 CTTNBP2NL SIPA1L1 PRKAR1B PLEKHA5	6.07e-06	209	160	8	36779422
Pubmed	New nomenclature for chromatin-modifying enzymes.	KMT2B NSD1 KDM6B SETD2 KMT2D	6.68e-06	57	160	5	18022353
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	FLNC SATB2 FOSL2 DACH1 TNIP1 SKI ECT2 TRIM3 CRACD NCOR1 ZC3H11A KMT2D PDS5A NOTCH2 NOVA2	1.09e-05	857	160	15	25609649
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	ANKS6 ANK2 CARMIL1 SLC9A1 AFAP1L2 PPP3CB PTPRF PPP1R37 PALM PLEKHA5 EPB41L1 NOTCH2	1.41e-05	569	160	12	30639242
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ANK2 TEX2 BCCIP PFAS TNIP1 CC2D1A GPRIN1 TTC3 NCKAP5L ATF6B TBC1D17 CEP89 ARHGEF10 PRKAR1B PALM MRPS5 PLEKHA5 SRRM2 EPB41L1 NOTCH2	1.76e-05	1487	160	20	33957083
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ARHGAP23 PFAS TNIP1 CCDC88C SETD2 KRBA1 AHRR LDB3 TNRC18 SSH1 PDS5A	1.94e-05	493	160	11	15368895
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SPEG CRACD ZC3H11A LRFN2 SIPA1L1 MAST1 CACNA1H SRRM2 EPB41L1 PDZD2	2.07e-05	407	160	10	12693553
Pubmed	Transmembrane tyrosine phosphatase LAR induces apoptosis by dephosphorylating and destabilizing p130Cas.	BCAR1 PTPRF	2.10e-05	2	160	2	10320483
Pubmed	A T-type calcium channel required for normal function of a mammalian mechanoreceptor.	CACNA1I CACNA1H	2.10e-05	2	160	2	12808460
Pubmed	NSD1 Inactivation and SETD2 Mutation Drive a Convergence toward Loss of Function of H3K36 Writers in Clear Cell Renal Cell Carcinomas.	NSD1 SETD2	2.10e-05	2	160	2	28754676
Pubmed	Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions.	NSD1 SETD2	2.10e-05	2	160	2	31060750
Pubmed	SH2-containing inositol 5'-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading.	INPPL1 BCAR1	2.10e-05	2	160	2	11158326
Pubmed	Rebound burst firing in the reticular thalamus is not essential for pharmacological absence seizures in mice.	CACNA1I CACNA1H	2.10e-05	2	160	2	25071191
Pubmed	Disruption of PLZP in mice leads to increased T-lymphocyte proliferation, cytokine production, and altered hematopoietic stem cell homeostasis.	KMT2D ZBTB32	2.10e-05	2	160	2	15542853
Pubmed	Whole Exome Sequencing of Hemiplegic Migraine Patients Shows an Increased Burden of Missense Variants in CACNA1H and CACNA1I Genes.	CACNA1I CACNA1H	2.10e-05	2	160	2	36786913
Pubmed	Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4).	KMT2B KMT2D	2.10e-05	2	160	2	35640156
Pubmed	Expression, Localization and Functional Activity of the Major Na⁺/H⁺ Exchange Isoforms Expressed in the Intestinal Cell Line Caco-2BBe.	SLC9A1 SLC9A2	2.10e-05	2	160	2	30977986
Pubmed	Are NHE1 and inducible nitric oxide synthase involved in human ovarian cancer?	SLC9A1 NOS2	2.10e-05	2	160	2	26821117
Pubmed	Comparison of methylation episignatures in KMT2B- and KMT2D-related human disorders.	KMT2B KMT2D	2.10e-05	2	160	2	35506254
Pubmed	PALML, a novel paralemmin-related gene mapping on human chromosome 1p21.	PALMD PALM	2.10e-05	2	160	2	11707320
Pubmed	Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation.	NSD1 SETD2	2.10e-05	2	160	2	18157086
Pubmed	Novel Cul3 binding proteins function to remodel E3 ligase complexes.	TRIM3 LRFN2 ZBTB32 DMWD	3.46e-05	40	160	4	25011449
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ZC3H14 SATB2 KMT2B IRF2BP1 C9orf78 FOSL2 DACH1 CC2D1A THOC2 NCOR1 TNRC18 ZC3H11A KMT2D SLBP PDS5A SRRM2	5.34e-05	1103	160	16	34189442
Pubmed	KMT2D regulates specific programs in heart development via histone H3 lysine 4 di-methylation.	MESP1 KMT2D CACNA1H	6.20e-05	17	160	3	26932671
Pubmed	Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C.	CACNA1I CACNA1H	6.29e-05	3	160	2	23488970
Pubmed	Programming of marginal zone B-cell fate by basic Kruppel-like factor (BKLF/KLF3).	KLF3 NOTCH2	6.29e-05	3	160	2	21297003
Pubmed	Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas.	KMT2D NOTCH2	6.29e-05	3	160	2	27566587
Pubmed	Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart.	CACNA1I CACNA1H	6.29e-05	3	160	2	11230107
Pubmed	Homeostatic plasticity and burst activity are mediated by hyperpolarization-activated cation currents and T-type calcium channels in neuronal cultures.	CACNA1I CACNA1H	6.29e-05	3	160	2	33547341
Pubmed	Calmodulin regulates Cav3 T-type channels at their gating brake.	CACNA1I CACNA1H	6.29e-05	3	160	2	28972185
Pubmed	SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling.	SATB2 MAPK7	6.29e-05	3	160	2	25662172
Pubmed	Alpha(1H) mRNA in single skeletal muscle fibres accounts for T-type calcium current transient expression during fetal development in mice.	CACNA1I CACNA1H	6.29e-05	3	160	2	11897840
Pubmed	Interferon-gamma suppresses Na+ -H+ exchanger in cultured human endolymphatic sac epithelial cells.	SLC9A1 SLC9A2	6.29e-05	3	160	2	19479940
Pubmed	Trefoil factor 2 requires Na/H exchanger 2 activity to enhance mouse gastric epithelial repair.	SLC9A1 SLC9A2	6.29e-05	3	160	2	21900251
Pubmed	Defective fluid secretion and NaCl absorption in the parotid glands of Na+/H+ exchanger-deficient mice.	SLC9A1 SLC9A2	6.29e-05	3	160	2	11358967
Pubmed	Targeted disruption of the Nhe1 gene prevents muscarinic agonist-induced up-regulation of Na(+)/H(+) exchange in mouse parotid acinar cells.	SLC9A1 SLC9A2	6.29e-05	3	160	2	10506152
Pubmed	The Na+/H+ exchanger isoform 2 is the predominant NHE isoform in murine colonic crypts and its lack causes NHE3 upregulation.	SLC9A1 SLC9A2	6.29e-05	3	160	2	14962844
Pubmed	Histone methyltransferase MLL4 controls myofiber identity and muscle performance through MEF2 interaction.	KMT2B KMT2D	6.29e-05	3	160	2	32544095
Pubmed	T-type channels: release a brake, engage a gear.	CACNA1I CACNA1H	6.29e-05	3	160	2	26488564
Pubmed	NHE1, NHE2, and NHE4 contribute to regulation of cell pH in T84 colon cancer cells.	SLC9A1 SLC9A2	6.29e-05	3	160	2	17943310
Pubmed	Differential interactions of Na+ channel toxins with T-type Ca2+ channels.	CACNA1I CACNA1H	6.29e-05	3	160	2	18591418
Pubmed	Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation.	CACNA1I CACNA1H	6.29e-05	3	160	2	28846697
Pubmed	Calcineurin homologous protein as an essential cofactor for Na+/H+ exchangers.	SLC9A1 SLC9A2	6.29e-05	3	160	2	11350981
Pubmed	Critical role for NHE1 in intracellular pH regulation in pancreatic acinar cells.	SLC9A1 SLC9A2	6.29e-05	3	160	2	12842825
Pubmed	JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factors.	KDM6B F8	6.29e-05	3	160	2	28328977
Pubmed	Expression, immunolocalization, and functional activity of Na+/H+ exchanger isoforms in mouse endometrial epithelium.	SLC9A1 SLC9A2	6.29e-05	3	160	2	12493726
Pubmed	The histone methyltransferase KMT2B is required for RNA polymerase II association and protection from DNA methylation at the MagohB CpG island promoter.	KMT2B KMT2D	6.29e-05	3	160	2	23358417
Pubmed	Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability.	CACNA1I CACNA1H	6.29e-05	3	160	2	11927664
Pubmed	Palm is expressed in both developing and adult mouse lens and retina.	PALMD PALM	6.29e-05	3	160	2	15969763
Pubmed	NHE2 is the main apical NHE in mouse colonic crypts but an alternative Na+-dependent acid extrusion mechanism is upregulated in NHE2-null mice.	SLC9A1 SLC9A2	6.29e-05	3	160	2	16690903
Pubmed	The proteins PDIP3 and ZC11A associate with the human TREX complex in an ATP-dependent manner and function in mRNA export.	THOC2 ZC3H11A	6.29e-05	3	160	2	22928037
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ZC3H14 KMT2B FOSL2 PHRF1 NSD1 ECT2 DENND1A CTTNBP2NL CRACD SCAF1 SETD2 SLC9A1 ZC3H11A SIPA1L1 MRPS5 PDS5A DGCR8 EPB41L1 ZNF574	6.31e-05	1497	160	19	31527615
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	PHACTR2 ARHGAP23 CARMIL1 INPPL1 CC2D1A GPRIN1 SLC9A1 PPP1R37 PLEKHA5 EPB41L1 NOTCH2	6.63e-05	565	160	11	25468996
Pubmed	High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface.	ANKS6 ARHGAP23 PHRF1 ZC3H18 PTPRF SLBP NOTCH2 ARHGAP33	9.41e-05	307	160	8	37499664
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	SPEG GPRIN1 TRIM3 SIPA1L1 SRRM2 EPB41L1 ARHGAP33	1.03e-04	231	160	7	16452087
Pubmed	Two miRNA clusters, miR-34b/c and miR-449, are essential for normal brain development, motile ciliogenesis, and spermatogenesis.	SATB2 KMT2B NSD1 NOTCH2	1.06e-04	53	160	4	24982181
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	KCNH8 DACH1 SCAF1 NCOR1 MAST1 SRRM2 CCDC17	1.08e-04	233	160	7	37704626
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	NUDT18 FLNC AMPH ANK2 ARHGAP23 PRR36 CARMIL1 RTN1 TRIM3 CRACD GAS2L1 SLC25A12 SIPA1L1 KNDC1 MAST1 PALM PLEKHA5 EPB41L1	1.11e-04	1431	160	18	37142655
Pubmed	CIN85 interacting proteins in B cells-specific role for SHIP-1.	IRF2BP1 INPPL1 SH3BP1 SLC25A12	1.14e-04	54	160	4	21725061
Pubmed	Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition.	KMT2B KDM6B KMT2D	1.20e-04	21	160	3	27626377
Pubmed	Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation.	KMT2B KMT2D	1.25e-04	4	160	2	19221051
Pubmed	Enhanced formation of a HCO3- transport metabolon in exocrine cells of Nhe1-/- mice.	SLC9A1 SLC9A2	1.25e-04	4	160	2	17890222
Pubmed	Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy.	CACNA1I CACNA1H	1.25e-04	4	160	2	28165634
Pubmed	The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin.	FLNC INPPL1	1.25e-04	4	160	2	11739414
Pubmed	Chromosomal assignment of four genes encoding Na/H exchanger isoforms in human and rat.	SLC9A1 SLC9A2	1.25e-04	4	160	2	8199403
Pubmed	NHE1, NHE2, and NHE3 contribute to regulation of intracellular pH in murine duodenal epithelial cells.	SLC9A1 SLC9A2	1.25e-04	4	160	2	10666043
Pubmed	Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.	BCAR1 PTPRF	1.25e-04	4	160	2	10822386
Pubmed	Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome.	ADAMTS1 NOS2	1.25e-04	4	160	2	28067899
Pubmed	Bcl-xL deamidation is regulated by multiple ion transporters and is intramolecularly catalyzed.	SLC9A1 SLC9A2	1.25e-04	4	160	2	29694915
Pubmed	MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing.	KMT2B KMT2D	1.25e-04	4	160	2	20808952
Pubmed	NSD1-deposited H3K36me2 directs de novo methylation in the mouse male germline and counteracts Polycomb-associated silencing.	NSD1 SETD2	1.25e-04	4	160	2	32929285
Pubmed	The Ski protein family is required for MeCP2-mediated transcriptional repression.	SKI NCOR1	1.25e-04	4	160	2	11441023
Pubmed	Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in mice.	KMT2B KMT2D	1.25e-04	4	160	2	23826075
Pubmed	A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity.	KMT2B KMT2D	1.25e-04	4	160	2	23129768
Pubmed	Na(+)-dependent transporters mediate HCO(3)(-) salvage across the luminal membrane of the main pancreatic duct.	SLC9A1 SLC9A2	1.25e-04	4	160	2	10841524
Pubmed	Contributions of Na+/H+ exchanger isoforms to preimplantation development of the mouse.	SLC9A1 SLC9A2	1.25e-04	4	160	2	9590530
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	FOSL2 NSD1 ZC3H11B BCAR1 TTC3 TNRC18 ZC3H11A ARHGEF10	1.61e-04	332	160	8	37433992
Pubmed	Tagging genes with cassette-exchange sites.	ENOX1 PHRF1 MCM10 FBXL19 ECT2 NCOR1 PPP1R37 DGCR8	1.71e-04	335	160	8	15741177
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	TEX2 INPPL1 NCKAP5L PHKA1 CEP89 SIPA1L1 PLEKHA5	1.71e-04	251	160	7	29778605
Pubmed	A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.	FLNC ANK2 PHKA1 LDB3	1.72e-04	60	160	4	19075228
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SATB2 TEX2 PHRF1 SFI1 KDM6B CTTNBP2NL BAHD1 CELSR3 PALM PLEKHA5	1.81e-04	529	160	10	14621295
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	ZC3H14 IRF2BP1 TEX2 PSKH1 PFAS CC2D1A FSCB SETD2 SLC9A2 PTPRF VAV2 ILKAP	2.05e-04	754	160	12	35906200
Pubmed	Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS).	ELK1 NOS2	2.08e-04	5	160	2	22065579
Interaction	TOP3B interactions	ZXDC RNF223 FLNC CRYBG2 ANKS6 KMT2B SPEG FOSL2 INPPL1 NSD1 PFAS CC2D1A SFI1 FBXL19 KDM6B THOC2 TTC3 DENND1A BAHD1 TBC1D17 GGT7 CCDC88C GAS2L1 SCAF1 NCOR1 TNRC18 ZC3H11A KMT2D CELSR3 PTPRF SSH1 CTDP1 PALM CACNA1H DMWD ANKRD33B NOTCH2 ARHGAP33	3.79e-11	1470	158	38	int:TOP3B
Interaction	YWHAH interactions	ZC3H14 PHACTR2 NHSL2 TEX2 SPEG CARMIL1 INPPL1 CC2D1A RIPK4 BCAR1 NCKAP5L ECT2 DENND1A CCDC88C SSH1 CEP89 SIPA1L1 OTUD7A MAP3K9 MAST1 PLEKHA5 MAPK7 DMWD SRRM2 EPB41L1 NOTCH2	4.51e-07	1102	158	26	int:YWHAH
Interaction	GSK3A interactions	ZC3H14 TEX2 INPPL1 BCCIP PFAS BCAR1 RTN1 CTTNBP2NL KRBA1 TNRC18 PPP3CB SIPA1L1 PRKAR1B PLEKHA5 SRRM2	3.92e-06	464	158	15	int:GSK3A
Interaction	DCAF7 interactions	ANKS6 KLF3 FBXL19 KDM6B SKI NCOR1 CBX6 KNDC1 PRKAR1B MAST1 MRPS5 SRRM2 ZNF574	6.93e-06	368	158	13	int:DCAF7
Interaction	TERF2IP interactions	NUDT18 ZC3H14 KMT2B C9orf78 DACH1 NSD1 ZC3H18 MCM10 THOC2 ECT2 NCOR1 SETD2 ZC3H11A PDS5A DGCR8 SRRM2	7.36e-06	552	158	16	int:TERF2IP
Interaction	SH3KBP1 interactions	ZC3H14 IRF2BP1 CARMIL1 INPPL1 SH3BP1 PALMD BCAR1 GAS2L1 TNRC18 PPP3CB PLEKHA5 SRRM2	7.43e-06	315	158	12	int:SH3KBP1
Interaction	YWHAZ interactions	TEX2 SPEG PFAS TNIP1 ZC3H18 RIPK4 BCAR1 NCKAP5L ECT2 DENND1A TRIM3 CCDC88C CRACD NCOR1 SLC9A1 PPP3CB SSH1 CEP89 SIPA1L1 MAP3K9 MAST1 PLEKHA5 MAPK7 DMWD NOS2 EPB41L1	1.21e-05	1319	158	26	int:YWHAZ
Interaction	MYOZ2 interactions	FLNC TCAP LDB3 PPP3CB	2.38e-05	22	158	4	int:MYOZ2
Interaction	ZMYND19 interactions	ZXDC ENOX1 ADAMTS1 SKI KRBA1 PPP1R37 PRKAR1B	4.06e-05	118	158	7	int:ZMYND19
Interaction	YWHAG interactions	PHACTR2 ARHGAP23 NHSL2 SPEG CARMIL1 RIPK4 BCAR1 NCKAP5L DENND1A CCDC88C CRACD SSH1 CEP89 SIPA1L1 OTUD7A MAP3K9 PLEKHA5 MAPK7 DMWD SRRM2 EFCAB7 NOS2 EPB41L1 NOTCH2	4.06e-05	1248	158	24	int:YWHAG
Interaction	SULF2 interactions	TNIP1 ZC3H18 TNRC18 PRKAR1B MRPS5 SRRM2 NOTCH2	4.28e-05	119	158	7	int:SULF2
Interaction	DIRAS3 interactions	PPM1D SLC9A1 FEZ2 CEP89 CBX6 MAP3K9 PALM PLEKHA5 EPB41L1 NOTCH2	4.30e-05	262	158	10	int:DIRAS3
Interaction	YWHAE interactions	BCCIP TNIP1 ZC3H18 RIPK4 BCAR1 MCM10 TTC3 NCKAP5L DENND1A CCDC88C CRACD SSH1 CEP89 SIPA1L1 MAP3K9 MAST1 PLEKHA5 MAPK7 DMWD SRRM2 EFCAB7 NOS2 EPB41L1 ARHGAP33	4.49e-05	1256	158	24	int:YWHAE
Interaction	YWHAB interactions	ARHGAP23 PPM1D SPEG BCCIP RIPK4 BCAR1 NCKAP5L ECT2 DENND1A CCDC88C SLC9A1 SSH1 CEP89 SIPA1L1 MAP3K9 MAST1 PLEKHA5 MAPK7 DMWD SRRM2 EPB41L1	4.52e-05	1014	158	21	int:YWHAB
Interaction	LHX8 interactions	FOSL2 KLF3 ATF6B LDB3 KMT2D	5.89e-05	53	158	5	int:LHX8
Interaction	OTUD7A interactions	ANK2 BCAR1 OTUD7B OTUD7A KNDC1	9.11e-05	58	158	5	int:OTUD7A
Interaction	ZNF623 interactions	PRKAR1B ZNF76 NOTCH2	9.88e-05	12	158	3	int:ZNF623
Interaction	RNGTT interactions	PHRF1 BCAR1 SCAF1 SETD2 CTDP1 SRRM2 ZNF574	1.05e-04	137	158	7	int:RNGTT
Interaction	DHX8 interactions	ZC3H14 C9orf78 PHRF1 TNIP1 ZC3H18 ECT2 SCAF1 SETD2 ZC3H11A SRRM2	1.06e-04	292	158	10	int:DHX8
Interaction	RAPGEF5 interactions	FLNC ANK2 ARHGAP23 ARHGEF10 PRKAR1B	1.07e-04	60	158	5	int:RAPGEF5
Interaction	RHOB interactions	PHACTR2 CARMIL1 INPPL1 CC2D1A MCM10 GPRIN1 NCKAP5L ECT2 CCDC88C SLC9A1 PTPRF CEP89 SIPA1L1 PALM MRPS5 PLEKHA5 EPB41L1 NOTCH2	1.08e-04	840	158	18	int:RHOB
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	KMT2B IRF2BP1 TBC1D17 SCAF1 ZSWIM9 ZBTB32 ZSCAN1 CEP89 PPP1R37 DMWD ARHGAP33 SERTAD3 NOVA2 ZNF574	8.62e-05	1192	161	14	chr19q13
Cytoband	22q13.1	SH3BP1 TST CBX6 CACNA1I	2.37e-04	85	161	4	22q13.1
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2B NSD1 SETD2 KMT2D	4.52e-05	34	106	4	487
GeneFamily	Zinc fingers CCCH-type	ZC3H14 ZC3H11B ZC3H18 ZC3H11A	5.08e-05	35	106	4	73
GeneFamily	PHD finger proteins	KMT2B PHRF1 NSD1 FBXL19 KMT2D	1.86e-04	90	106	5	88
GeneFamily	Ankyrin repeat domain containing	ACAP1 ANKS6 ANK2 RIPK4 ANKRD30A ANKRD33B NOTCH2	5.59e-04	242	106	7	403
GeneFamily	PDZ domain containing	ARHGAP23 LDB3 SIPA1L1 MAST1 PDZD2	2.02e-03	152	106	5	1220
GeneFamily	Zinc fingers CXXC-type	KMT2B FBXL19	2.16e-03	12	106	2	136
GeneFamily	N-BAR domain containing	AMPH SH3BP1	2.16e-03	12	106	2	1289
GeneFamily	Basic leucine zipper proteins	NRL FOSL2 ATF6B	2.97e-03	49	106	3	506
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP23 SH3BP1 ARHGAP33	3.14e-03	50	106	3	721
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	PHRF1 SFI1 NCOR1 SLC9A1 PPP1R37	4.27e-03	181	106	5	694
GeneFamily	Protein phosphatases, Mg2+/Mn2+ dependent	PPM1D ILKAP	4.37e-03	17	106	2	701
GeneFamily	OTU domain containing	OTUD7B OTUD7A	4.37e-03	17	106	2	669
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ECT2 ARHGEF10 VAV2	6.86e-03	66	106	3	722
GeneFamily	PWWP domain containing	HDGFL1 NSD1	7.29e-03	22	106	2	1147
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ACAP1 ARHGAP23 AFAP1L2 PLEKHA5 VAV2	7.32e-03	206	106	5	682
GeneFamily	Claudins	CLDN2 CLDN19	7.95e-03	23	106	2	488
GeneFamily	Ataxins\|Trinucleotide repeat containing	TNRC18 KMT2D	9.36e-03	25	106	2	775
GeneFamily	Calcium voltage-gated channel subunits	CACNA1I CACNA1H	1.01e-02	26	106	2	253
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN	FLNC CRYBG2 ENOX1 FOSL2 GPR135 SLC39A4 RIPK4 SFI1 MCM10 KDM6B SKI RTN1 LDB3 ZBTB32 MAP3K9 ZNF76 CACNA1I CACNA1H ELK1	2.57e-06	909	158	19	M41018
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Intermediate\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	ACAP1 SH3BP1 MESP1 FBXL19 TRIM3 OTUD7B SLC45A2	2.68e-07	120	160	7	eb5b88c47dd4a6f9b55ace24f19d4e81d4ed31e1
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AMPH ENOX1 ADAMTS1 NHSL2 COL5A3 AFAP1L2 CACNA1H PDZD2	3.53e-07	184	160	8	327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCell	Posterior_cortex-Neuronal\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	SH3BP1 PANX2 GPRIN1 TTC3 RTN1 MAP3K9 PRKAR1B MAST1	5.07e-07	193	160	8	b4989e3436e84dbec3789b46057e0f7a0ebf09d4
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	SATB2 ANK2 PALMD TTC3 RTN1 CRACD MAP3K9 MAST1	6.63e-07	200	160	8	5b3df61ff421846ef4cabf1bd5355534c8b95509
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	ENOX1 ADAMTS1 DACH1 COL5A3 AFAP1L2 HES7 CACNA1H	2.90e-06	171	160	7	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAMTS1 PALMD F8 CTTNBP2NL AHRR AFAP1L2 NOVA2	3.25e-06	174	160	7	18ab52d8bbca0507fee220e0c4fc765fc47dda34
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA4D SATB2 DACH1 RTN1 MAP3K9 MAST1 PDZD2	3.38e-06	175	160	7	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGAP23 F8 SSH1 ANKRD30A PALM MAPK7 NOVA2	3.92e-06	179	160	7	9fd9b136ecbcbd4e4f0d5875ede98d8d48608afb
ToppCell	droplet-Limb_Muscle-Pre-Sort\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS1 SPEG FOSL2 KDM6B LDB3 CACNA1H CLDN19	4.07e-06	180	160	7	af2bafcd1b2082629de3ea336711add01565c4c4
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS1 SPEG FOSL2 KDM6B LDB3 CACNA1H CLDN19	4.07e-06	180	160	7	f29a995cf6e1a1836ed68b73258d9370bf3d4434
ToppCell	COVID-19-Heart-EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADAMTS1 DACH1 COL5A3 PALMD F8 CACNA1H PDZD2	4.37e-06	182	160	7	e67f3234165199085c793915ebb1f9bbd845e933
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	FLNC ANK2 PALMD TCAP LDB3 PLEKHA5 PDZD2	4.70e-06	184	160	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ADAMTS1 DACH1 PALMD F8 CTTNBP2NL ANKRD33B PDZD2	4.70e-06	184	160	7	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	ENOX1 ADAMTS1 DACH1 COL5A3 LDB3 AFAP1L2 CACNA1H	4.87e-06	185	160	7	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	droplet-Lung-LUNG-1m-Epithelial-Club_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNH8 LAMA3 JSRP1 CRACD AFAP1L2 CLDN19 EFCAB7	5.04e-06	186	160	7	e52cf44989c57c433bf82e9fa13b4643e88f3577
ToppCell	droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNH8 LAMA3 JSRP1 CRACD AFAP1L2 CLDN19 EFCAB7	5.04e-06	186	160	7	4c0b59d845b79323e7a3287e7c4d249f5f322556
ToppCell	COVID-19-Heart-Mito_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLNC PALMD MESP1 JSRP1 F8 TCAP LDB3	5.80e-06	190	160	7	ea74e0e38bcaba125b48c88331e9ba09228d3178
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	ENOX1 ADAMTS1 SPEG COL5A3 LDB3 AFAP1L2 CACNA1H	6.65e-06	194	160	7	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ENOX1 ADAMTS1 DACH1 COL5A3 LDB3 AFAP1L2 CACNA1H	7.35e-06	197	160	7	41dd312f46a2b983c8d864adeb6970c0ca4a8048
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SATB2 ADAMTS1 LAMA3 COL5A3 LDB3 CACNA1H ANKRD33B	7.59e-06	198	160	7	b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DACH1 PALMD F8 CTTNBP2NL AFAP1L2 ANKRD33B NOVA2	7.59e-06	198	160	7	002424b24dacac553e02d0f764a6e8a1e567b9df
ToppCell	Frontal_cortex-Neuronal\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	GPRIN1 TTC3 RTN1 PPP3CB CELSR3 MAP3K9 PRKAR1B	7.85e-06	199	160	7	f88039d862f3bfa01dc39d2de4f3f548dc5a0e61
ToppCell	Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DACH1 PALMD BCAR1 F8 TRIM3 GAS2L1 SCAF1	8.11e-06	200	160	7	a8b59e6fe04271fef61db911a286b5c48438bb84
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	SATB2 PALMD TTC3 RTN1 CTTNBP2NL MAST1	1.60e-05	148	160	6	a1269312903fc27830c1835dabf660c659a711be
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLNC PSKH1 ECT2 CRACD ZSWIM9 ARHGAP33	2.23e-05	157	160	6	bd45590da540a557dc8096980a45220fccb99505
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLNC PSKH1 ECT2 CRACD ZSWIM9 ARHGAP33	2.23e-05	157	160	6	00c9a58b033b8b95b0d838f233dd077b62d8b02a
ToppCell	facs-Aorta-Heart-24m-Endothelial-coronary_vascular_endothelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP1 DACH1 ZC3H18 PALMD BCAR1 NOS2	2.85e-05	164	160	6	5ee3729fab794d7acb172d14ec5d91aa1a61cd61
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D122\|Adult / Lineage, Cell type, age group and donor	SPEG PALMD F8 GAS2L1 AFAP1L2 NOVA2	3.27e-05	168	160	6	8c3e1e45b422813bcdfa4273b1167db649a312f5
ToppCell	facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TEX2 CARMIL1 GPR135 SLC9A1 PTPRF ARHGEF10	3.61e-05	171	160	6	6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794
ToppCell	facs\|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KMT2B SH3BP1 PFAS KDM6B CCDC88C NOTCH2	3.61e-05	171	160	6	c9990bc041a632b2f7bbebbfe737772c423d7027
ToppCell	facs-Marrow-T-cells-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TEX2 CARMIL1 GPR135 SLC9A1 PTPRF ARHGEF10	3.61e-05	171	160	6	e02b5831768dbb1b68998b672e55c9680ab0cc86
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TEX2 FBXL19 PHKA1 KRBA1 TXLNB ANKRD33B	3.85e-05	173	160	6	62abaaaf48cabd1423f17fb27c33b75ea88867f4
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRYBG2 PHACTR2 FOSL2 KDM6B GAS2L1 NOTCH2	3.85e-05	173	160	6	0f9c1d3298e59e6d22bb3306f0f445f490be8bbd
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TEX2 FBXL19 PHKA1 KRBA1 TXLNB ANKRD33B	3.85e-05	173	160	6	09cd878c33534bd476d6a4880f5582076189da8c
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCM10 F8 CLDN2 SCAF1 AFF1 ANKRD33B	3.98e-05	174	160	6	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZC3H14 SH3BP1 MCM10 GGT7 MAP3K9 PLEKHA5	3.98e-05	174	160	6	09b091e24317c3f7bac043f04762a533e30793de
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CARMIL1 LAMA3 FBXL19 PTPRF HES7 ARHGAP33	4.10e-05	175	160	6	96219e58dcb327fd27190be78193e7a0d611e62b
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D175\|Adult / Lineage, Cell type, age group and donor	ADAMTS1 DACH1 PALMD AFAP1L2 SLC45A2 NOVA2	4.10e-05	175	160	6	0a65ddfa8c2e8efb5b5338cf07661cb78157a23c
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CARMIL1 LAMA3 FBXL19 PTPRF HES7 ARHGAP33	4.10e-05	175	160	6	cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DACH1 NSD1 KLF3 PALMD CCDC88C SRRM2	4.51e-05	178	160	6	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SATB2 NHSL2 PALMD CCDC88C ANKRD33B PDZD2	4.66e-05	179	160	6	9ba8693fba2175bca9ff9735cc04e657abeb9084
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADAMTS1 DACH1 PALMD F8 CTTNBP2NL PDZD2	4.66e-05	179	160	6	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SATB2 ANK2 SCAF1 AFAP1L2 EFCAB7 PDZD2	4.95e-05	181	160	6	274c0b768925cd5804483303f8c5ebd17a534c41
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	DACH1 LAMA3 COL5A3 CACNA1H EPB41L1 PDZD2	4.95e-05	181	160	6	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	CARMIL1 DACH1 LAMA3 COL5A3 CACNA1H PDZD2	5.11e-05	182	160	6	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PFAS PHKA1 CRACD REM2 NOS2 PGBD5	5.11e-05	182	160	6	d1c3cc2942faec7527a3c25869fd65c17899e5e4
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PFAS PHKA1 CRACD REM2 NOS2 PGBD5	5.11e-05	182	160	6	92f83f29e358000cd86a709eb8b6199761ffe8bd
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PFAS PHKA1 CRACD REM2 NOS2 PGBD5	5.11e-05	182	160	6	02baca9a72c7b559c3e452693b3b134af804c868
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK2 COL5A3 BCAR1 KDM6B TTC3 SLC45A2	5.26e-05	183	160	6	a0a3e4d07ac73dbbb1e019fd11e88ccffe6cf2ca
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SATB2 NHSL2 PALMD CCDC88C SIPA1L1 PDZD2	5.26e-05	183	160	6	1645d4a55cd8c22d6eb47fc5c6b1e576c454f111
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SATB2 NHSL2 PALMD CCDC88C SIPA1L1 PDZD2	5.43e-05	184	160	6	34e316ad8e7b8667cd8ad61397281802a252744f
ToppCell	Endothelial-A-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	ARHGAP23 ADAMTS1 DACH1 PALMD AFAP1L2 NOVA2	5.59e-05	185	160	6	ae49c61f6ecf128fe2a958b8c75c83688da75f59
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ENOX1 COL5A3 AHRR AFAP1L2 HES7 CACNA1H	5.59e-05	185	160	6	a7dba7db79275884b2a93d8a16f2e0c739e71370
ToppCell	10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FLNC ARHGAP23 COL5A3 LDB3 OTUD7A EFCAB7	5.59e-05	185	160	6	0094f9baddb20214d2a2c166f1637d1a9cf1169a
ToppCell	LPS_only\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACAP1 FOSL2 TNIP1 KDM6B AFF1 ANKRD33B	5.59e-05	185	160	6	a72ccb147ca505880e2da8f6a70b9d570464a691
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	ANK2 PALMD TCAP LDB3 PLEKHA5 PDZD2	5.59e-05	185	160	6	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAMTS1 PPM1D DACH1 PALMD CTTNBP2NL AFAP1L2	5.59e-05	185	160	6	a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PHACTR2 DACH1 SLC9A2 AFAP1L2 APCDD1L EPB41L1	5.76e-05	186	160	6	d65fa6d8e8a195ea10cfde1499d096d6acf7a634
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC39A4 PALMD KDM6B NCKAP5L PTPRF CBX6	5.76e-05	186	160	6	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	Adult-Endothelial-endothelial_cell_of_artery\|Adult / Lineage, Cell type, age group and donor	ADAMTS1 DACH1 PALMD F8 AFAP1L2 NOVA2	5.76e-05	186	160	6	2d1c4ea2e401db89971582ee54618a8b0c81b8ac
ToppCell	Control-Endothelial_cells-Arterial_endothelial_cells\|Control / group, cell type (main and fine annotations)	ADAMTS1 PPM1D DACH1 PALMD F8 CTTNBP2NL	5.93e-05	187	160	6	81affaab3fe3e1daea45ada6445e906ddd33950e
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ENOX1 COL5A3 BCAR1 AHRR AFAP1L2 CACNA1H	5.93e-05	187	160	6	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS1 KLF3 PALMD KDM6B NCOR1 SRRM2	6.11e-05	188	160	6	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NHSL2 CARMIL1 JSRP1 TTC3 ZC3H11A TXLNB	6.11e-05	188	160	6	2156f1bc849ff1cb09ae296d13bedd913ae6b43b
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ENOX1 DACH1 COL5A3 LDB3 AFAP1L2 CACNA1H	6.11e-05	188	160	6	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	Endothelial-endothelial_cell_of_artery\|World / Lineage, Cell type, age group and donor	ADAMTS1 DACH1 PALMD F8 CTTNBP2NL NOVA2	6.29e-05	189	160	6	fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAMTS1 PPM1D DACH1 PALMD CTTNBP2NL AFAP1L2	6.48e-05	190	160	6	f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADAMTS1 PPM1D DACH1 PALMD F8 CTTNBP2NL	6.67e-05	191	160	6	50601ef0a5a8f2c2120922989e08e85bf2d9b4ab
ToppCell	15\|World / Age, Tissue, Lineage and Cell class	RTN1 ATF6B CCDC88C PTPRF CBX6 CCDC17	7.07e-05	193	160	6	a8ad0de955494d6f5929dc44ba46627d06d95453
ToppCell	Control-Endothelial-VE_Arterial\|World / Disease state, Lineage and Cell class	ARHGAP23 ADAMTS1 DACH1 PALMD F8 NOVA2	7.07e-05	193	160	6	52c0f2c7af57436f23e0c0e0c87086c47695e2c4
ToppCell	Thalamus-Neuronal\|Thalamus / BrainAtlas - Mouse McCarroll V32	GPRIN1 TTC3 PPP3CB CELSR3 PRKAR1B MAST1	7.07e-05	193	160	6	712a4acd1167e43543950bc819ff11984e6f718d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FOSL2 CARMIL1 PANX2 SLC9A2 AFAP1L2 APCDD1L	7.07e-05	193	160	6	d994b2f2707877288f88cab7cd6002ef91962c50
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	KCNH8 PRR36 LAMA3 RIPK4 RBBP8NL PTPRF	7.27e-05	194	160	6	acd5ba9a097595d4caab4f05440531c65a4aa7bc
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PHACTR2 ENOX1 PHKA1 CRACD SLC9A2 VAV2	7.27e-05	194	160	6	e5990880961d2469759ce4b3b20ae93ace3ebd1f
ToppCell	Control-Myeloid-ncMonocyte\|Control / Disease state, Lineage and Cell class	PSTPIP2 CTTNBP2NL CCDC88C SIPA1L1 VAV2 NOTCH2	7.48e-05	195	160	6	fcb05948e7480dc53f06f3fc9b9c3fc129874edd
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FOSL2 CARMIL1 DACH1 SLC9A2 AFAP1L2 APCDD1L	7.48e-05	195	160	6	e94bac6a5c788ee160d7feaf2a3c512a3691f995
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn\|World / Primary Cells by Cluster	SEMA4D SATB2 ANK2 PALMD TTC3 RTN1	7.69e-05	196	160	6	9401bd84798f0ea3e986e94135a9e1dc5643330f
ToppCell	wk_08-11-Epithelial-PNS-TM4SF4+_PENK+_neuron\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ENOX1 GPRIN1 RTN1 PPP2R5B LRFN2 REM2	7.69e-05	196	160	6	afa3a2f5f3a51d1830c6f95f97a4b3e13ed42512
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS1 SPEG FOSL2 LDB3 HES7 CACNA1H	7.91e-05	197	160	6	cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ENOX1 DACH1 COL5A3 LDB3 AFAP1L2 CACNA1H	7.91e-05	197	160	6	f66945f9007d59d4208849c7fd727f8519713fbc
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_PFC-23\|World / Primary Cells by Cluster	SATB2 MESP1 TTC3 RTN1 NCOR1 SLBP	7.91e-05	197	160	6	def63e7e28dd398722e528b7816a34de92552419
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_PFC\|World / Primary Cells by Cluster	SATB2 MESP1 TTC3 RTN1 NCOR1 SLBP	7.91e-05	197	160	6	26fd54acd90292a01ef0d892ba16ccdade987f36
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FLNC SATB2 SPEG LDB3 HES7 CACNA1H	7.91e-05	197	160	6	b67ffd27d386c8186ef71ecdac96a462504507f0
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	ARHGAP23 ADAMTS1 PALMD F8 PALM NOVA2	8.14e-05	198	160	6	56b746e5791b47fe33a7872f0942ae0747b13d4a
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	ARHGAP23 ADAMTS1 DACH1 PALMD F8 CTTNBP2NL	8.14e-05	198	160	6	531b0f88c95f813e3914c96749f591e80ca321d0
ToppCell	Endothelial_cells\|World / lung cells shred on cell class, cell subclass, sample id	ADAMTS1 DACH1 PALMD F8 PALM NOVA2	8.14e-05	198	160	6	b93effa428ec036542fa21647dfef9589c64640f
ToppCell	Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ENOX1 DACH1 COL5A3 AFAP1L2 HES7 CACNA1H	8.36e-05	199	160	6	929f809579368201331d9099d8904b6e3c41797b
ToppCell	Transverse-T_cell-Tfh\|T_cell / Region, Cell class and subclass	NSD1 PFAS FBXL19 JSRP1 NCKAP5L ECT2	8.36e-05	199	160	6	33ffea12b8228e0b5bd8942531c3b21d24224725
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	SATB2 PALMD TTC3 RTN1 CRACD MAST1	8.36e-05	199	160	6	a255484ba77bd2741a541da278efc8cf4abbe570
ToppCell	Bronchial-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ENOX1 DACH1 COL5A3 AFAP1L2 HES7 CACNA1H	8.36e-05	199	160	6	854628ce91068093c14bd4d45ba38c41469f3549
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Artery-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADAMTS1 DACH1 PALMD F8 TCAP NOVA2	8.60e-05	200	160	6	622206c33640cb2694fe158e8dc55515bb7bd4f5
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-Neurons\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	SATB2 PALMD TTC3 RTN1 CTTNBP2NL MAST1	8.60e-05	200	160	6	b9538eb33ac86384e7e289a5a82fac4d56a7b9c2
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Artery\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ADAMTS1 DACH1 PALMD F8 TCAP NOVA2	8.60e-05	200	160	6	5b4a54cd81bc4d9f5e92798362239e1aa1b70bee
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Artery\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	ADAMTS1 DACH1 PALMD F8 TCAP NOVA2	8.60e-05	200	160	6	590d1c0f86f136c7e76ea107fbb8ac5ff1164386
ToppCell	Neuronal-Excitatory-eA(LAMP5_LINC00507)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SATB2 NHSL2 PALMD CCDC88C SIPA1L1 PDZD2	8.60e-05	200	160	6	0f23e72649a274043bf23e0952a9b5707c516acf
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Interneuron\|1m / Sample Type, Dataset, Time_group, and Cell type.	ARHGAP23 KDM6B RTN1 XKR7 CCDC17 PGBD5	8.60e-05	200	160	6	fc839e9c33ea1d4ee0f42f21fd32a54e7cbe1f5a
ToppCell	LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CRYBG2 FAM185A CLDN2 ZSCAN1 CACNA1H	9.94e-05	128	160	5	082b3dc312b033c9b21cf73499009a1dc049ee2b
ToppCell	Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS1 COL5A3 LDB3 AFAP1L2 CACNA1H	1.23e-04	134	160	5	bffd6ce8998368d4f486b64c220eab3a44ba147b
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	LAMA3 PFAS RTN1 AHRR TNRC18	1.23e-04	134	160	5	72d7eec3aeb43319f3ef81bb5518fae8d8880136
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cpa6_Gpr88\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SATB2 DACH1 PALMD JSRP1 ANKRD33B	1.62e-04	142	160	5	84742a7e35bab09ee1cca80cfe120b613d6aed6a
Drug	Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	ZC3H14 PALMD MCM10 GAS2L1 CTDP1 PRKAR1B DGCR8 MAPK7 DMWD VAV2 ARHGAP33	9.63e-08	194	155	11	4325_DN
Drug	Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A	NUDT18 IRF2BP1 FOSL2 LAMA3 KLF3 RIPK4 SLC9A1 PTPRF SSH1 CACNA1I EPB41L1	1.25e-07	199	155	11	5337_UP
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	FOSL2 SH3BP1 SFI1 NCOR1 PTPRF CTDP1 PALM CACNA1H MAPK7 DMWD	8.59e-07	193	155	10	3262_UP
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A	SEMA4D PRR36 TRIM3 CELSR3 ARHGEF10 PRKAR1B CACNA1H SRRM2 VAV2 ZNF574	1.13e-06	199	155	10	3344_DN
Drug	Letrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A	IRF2BP1 FOSL2 GAS2L1 SLC9A2 PRKAR1B PALM AFF1 ZNF76 MAPK7	7.27e-06	193	155	9	4240_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A	SEMA4D KMT2B CC2D1A SFI1 BAHD1 PTPRF ARHGEF10 CTDP1 ZNF76	7.90e-06	195	155	9	5117_DN
Drug	Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A	FLNC CRYBG2 NRL SFI1 TRIM3 PPP2R5B CACNA1I CACNA1H SRRM2	7.90e-06	195	155	9	2897_UP
Drug	Aminophylline [317-34-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	NUDT18 SEMA4D KDM6B TBC1D17 SLC9A2 PPP1R37 PALM ELK1 ARHGAP33	8.23e-06	196	155	9	3374_DN
Drug	Thyroxine (L) [51-48-9]; Down 200; 5.2uM; HL60; HT_HG-U133A	ACAP1 DACH1 NSD1 SETD2 SLC9A1 SIPA1L1 NOTCH2 ARHGAP33 ZNF574	8.23e-06	196	155	9	1312_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A	SFI1 TRIM3 HOXD11 MAP3K9 PALM AFF1 SLC45A2 MAPK7 VAV2	8.57e-06	197	155	9	4433_UP
Drug	Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; MCF7; HT_HG-U133A	FOSL2 SLC39A4 TST TBC1D17 CBX6 CACNA1H MAPK7 SRRM2 ARHGAP33	8.57e-06	197	155	9	1709_UP
Drug	Austricine [10180-88-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A	CRYBG2 NRL FOSL2 SFI1 PALM DGCR8 VAV2 PGBD5 NOTCH2	8.57e-06	197	155	9	4797_UP
Drug	Scoulerine [6451-73-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A	TBC1D17 LDB3 PPP2R5B HOXD11 CACNA1I CACNA1H ARHGAP33 NOVA2 PDZD2	8.93e-06	198	155	9	2891_UP
Drug	S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A	CRYBG2 SFI1 TRIM3 TBC1D17 GAS2L1 PPP2R5B ARHGEF10 PALM DGCR8	8.93e-06	198	155	9	3393_UP
Drug	6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A	CRYBG2 PRR36 SFI1 LDB3 AFF1 SLC45A2 MAPK7 DMWD ARHGAP33	8.93e-06	198	155	9	6073_UP
Drug	silyloxide	DACH1 NSD1 F8	1.69e-05	8	155	3	CID006327218
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	IRF2BP1 FOSL2 DACH1 KLF3 PRKAR1B CACNA1I SRRM2 VAV2	2.13e-05	169	155	8	6064_DN
Drug	4-bromo-2-methylbenzoic acid	SLC9A1 SLC9A2	4.60e-05	2	155	2	CID000099570
Drug	GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A	PSKH1 FOSL2 SKI SETD2 SLC9A1 MAP3K9 PRKAR1B PDS5A	4.91e-05	190	155	8	7070_UP
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA	IRF2BP1 FOSL2 KDM6B TRIM3 SETD2 SLC9A2 PPP2R5B ELK1	5.29e-05	192	155	8	849_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	ZXDC SATB2 RIPK4 KDM6B GAS2L1 PRKAR1B DGCR8 EPB41L1	5.29e-05	192	155	8	6986_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	PHACTR2 KMT2B PFAS ARHGEF10 SIPA1L1 PDS5A ELK1 ZNF574	5.69e-05	194	155	8	2523_DN
Drug	Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A	SEMA4D NRL GPR135 LDB3 PPP2R5B PRKAR1B CACNA1H ARHGAP33	5.69e-05	194	155	8	2893_UP
Drug	Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A	IRF2BP1 PRR36 FOSL2 SFI1 PPP2R5B PPP1R37 DGCR8 MAPK7	5.69e-05	194	155	8	3245_UP
Drug	Resveratrol [501-36-0]; Up 200; 17.6uM; MCF7; HT_HG-U133A	NUDT18 SEMA4D FOSL2 GPR135 CAMK1G SIPA1L1 CACNA1H DMWD	5.89e-05	195	155	8	2865_UP
Drug	DL-PPMP; Down 200; 2uM; MCF7; HT_HG-U133A_EA	ZXDC SEMA4D FOSL2 INPPL1 KLF3 RIPK4 GAS2L1 ELK1	5.89e-05	195	155	8	1121_DN
Drug	Sulfaphenazole [526-08-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A	NUDT18 TRIM3 TBC1D17 PPP2R5B ARHGEF10 CACNA1H ELK1 DMWD	6.11e-05	196	155	8	1673_UP
Drug	Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; HL60; HT_HG-U133A	PSKH1 FOSL2 CC2D1A SFI1 SLC9A1 ARHGEF10 DMWD ZNF574	6.11e-05	196	155	8	2913_UP
Drug	Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A	IRF2BP1 PRR36 KDM6B CELSR3 CTDP1 DMWD SRRM2 NOTCH2	6.11e-05	196	155	8	3233_DN
Drug	Mifepristone [84371-65-3]; Down 200; 9.4uM; HL60; HG-U133A	IRF2BP1 SFI1 MCM10 TRIM3 CCDC88C SLC9A1 CTDP1 AFF1	6.11e-05	196	155	8	1569_DN
Drug	Iocetamic acid [16034-77-8]; Up 200; 6.6uM; PC3; HT_HG-U133A	ENOX1 SFI1 KDM6B PALM AFF1 CACNA1I SRRM2 NOTCH2	6.11e-05	196	155	8	4600_UP
Drug	Dequalinium dichloride [522-51-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A	IRF2BP1 TBC1D17 CTDP1 MAP3K9 MAPK7 VAV2 EPB41L1 PGBD5	6.11e-05	196	155	8	5396_DN
Drug	Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A	NUDT18 IRF2BP1 NCOR1 PPP2R5B CBX6 SLC45A2 MAPK7 PGBD5	6.11e-05	196	155	8	1508_UP
Drug	LY294002; Down 200; 10uM; MCF7; HG-U133A	FOSL2 SLC9A1 MAP3K9 PRKAR1B PDS5A VAV2 NOTCH2 ILKAP	6.11e-05	196	155	8	328_DN
Drug	Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; HL60; HT_HG-U133A	NUDT18 KMT2B KLF3 SFI1 KDM6B SIPA1L1 ELK1 DGCR8	6.11e-05	196	155	8	2736_DN
Drug	Harmane hydrochloride [21655-84-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A	ACAP1 PRR36 GAS2L1 LDB3 HOXD11 DGCR8 DMWD NOVA2	6.33e-05	197	155	8	4408_UP
Drug	Sulpiride [15676-16-1]; Up 200; 11.8uM; PC3; HG-U133A	FOSL2 INPPL1 KDM6B PPP2R5B ELK1 DGCR8 MAPK7 EPB41L1	6.33e-05	197	155	8	1887_UP
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A	SEMA4D FOSL2 NSD1 PSTPIP2 NCOR1 SLC9A1 CTDP1 PRKAR1B	6.33e-05	197	155	8	5360_UP
Drug	Doxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	NUDT18 SEMA4D PRR36 LAMA3 TRIM3 NCOR1 CTDP1 PRKAR1B	6.33e-05	197	155	8	1473_DN
Drug	Trichlormethiazide [133-67-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A	SEMA4D PRR36 KLF3 SKI BAHD1 TRIM3 NCOR1 PGBD5	6.33e-05	197	155	8	3337_DN
Drug	(+,-)-Synephrine [94-07-5]; Up 200; 24uM; MCF7; HT_HG-U133A	ACAP1 CRYBG2 PRR36 DACH1 ZNF76 CACNA1I VAV2 NOVA2	6.33e-05	197	155	8	6798_UP
Drug	Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; HL60; HT_HG-U133A	CRYBG2 DACH1 SFI1 TRIM3 CELSR3 CACNA1I ARHGAP33 ZNF574	6.33e-05	197	155	8	2934_UP
Drug	2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A	SEMA4D KMT2B TEX2 FOSL2 INPPL1 SLC39A4 TNIP1 SRRM2	6.33e-05	197	155	8	1181_DN
Drug	Astemizole [68844-77-9]; Down 200; 8.8uM; MCF7; HT_HG-U133A	NUDT18 SEMA4D IRF2BP1 SFI1 SLC9A2 CTDP1 MAP3K9 SRRM2	6.56e-05	198	155	8	2211_DN
Drug	Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A	AMPH ENOX1 KLF3 PSTPIP2 TRIM3 PPP2R5B HOXD11 CACNA1H	6.56e-05	198	155	8	4422_UP
Drug	novobiocin sodium, USP; Up 200; 100uM; PC3; HG-U133A	CRYBG2 FOSL2 SH3BP1 PPP1R37 AFF1 PDS5A CACNA1I ARHGAP33	6.56e-05	198	155	8	435_UP
Drug	Metolazone [17560-51-9]; Down 200; 11uM; MCF7; HT_HG-U133A	DACH1 CCDC88C HOXD11 PRKAR1B VAV2 PGBD5 NOTCH2 ZNF574	6.56e-05	198	155	8	5392_DN
Drug	Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A	FOSL2 SFI1 KDM6B MAP3K9 PALM ZNF76 MAPK7 VAV2	6.56e-05	198	155	8	2845_UP
Drug	Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A	ZXDC SEMA4D FOSL2 DACH1 KDM6B CCDC88C SLC9A1 PRKAR1B	6.56e-05	198	155	8	3434_DN
Drug	Glycocholic acid [475-31-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A	DACH1 GPR135 SETD2 SLC9A2 AFF1 ELK1 MAPK7 VAV2	6.56e-05	198	155	8	5316_UP
Drug	Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; MCF7; HT_HG-U133A	IRF2BP1 GPR135 SFI1 SETD2 CACNA1I SRRM2 ARHGAP33 NOVA2	6.80e-05	199	155	8	3541_UP
Drug	Zimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; HL60; HG-U133A	ACAP1 PHACTR2 COL5A3 CELSR3 ARHGEF10 PDS5A DGCR8 ARHGAP33	6.80e-05	199	155	8	2012_UP
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A	NUDT18 TRIM3 SLC45A2 CACNA1H DGCR8 SRRM2 PGBD5 NOTCH2	6.80e-05	199	155	8	3640_DN
Drug	Spaglumic acid [4910-46-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	IRF2BP1 SFI1 CELSR3 CTDP1 PRKAR1B AFF1 VAV2 EPB41L1	6.80e-05	199	155	8	7465_UP
Drug	Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	ZXDC SEMA4D FOSL2 LAMA3 GAS2L1 SLC9A2 PTPRF ARHGEF10	6.80e-05	199	155	8	6214_DN
Drug	PHA-00851261E [724719-49-7]; Up 200; 1uM; MCF7; HT_HG-U133A	CRYBG2 CAMK1G SFI1 PPP2R5B ZNF76 SLC45A2 CACNA1H NOS2	7.04e-05	200	155	8	3968_UP
Drug	CAY10397; Up 200; 10uM; MCF7; HT_HG-U133A	NUDT18 IRF2BP1 PSKH1 LAMA3 PRKAR1B PALM ZNF76 DGCR8	7.04e-05	200	155	8	7082_UP
Drug	Xylazine [7361-61-7]; Up 200; 18.2uM; MCF7; HT_HG-U133A	PRR36 SPEG SKI CELSR3 HOXD11 PPP1R37 CACNA1I ARHGAP33	7.04e-05	200	155	8	2788_UP
Drug	Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; MCF7; HT_HG-U133A	NUDT18 FOSL2 LDB3 ARHGEF10 MAP3K9 ZNF76 CACNA1I NOVA2	7.04e-05	200	155	8	2633_UP
Drug	Fenbendazole [43210-67-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	SEMA4D FOSL2 CC2D1A PALMD KDM6B TRIM3 PRKAR1B DGCR8	7.04e-05	200	155	8	4542_DN
Drug	Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; PC3; HT_HG-U133A	SFI1 CCDC88C SLC9A1 PPP2R5B ELK1 MAPK7 SRRM2 EPB41L1	7.04e-05	200	155	8	5831_DN
Drug	fullerene C60	ZXDC SATB2 FOSL2 INPPL1 PFAS TNIP1 CAMK1G BCAR1 KDM6B GPRIN1 NCOR1 LDB3 PPP2R5B CEP89 PPP1R37 PRKAR1B CACNA1I REM2 ANKRD33B PGBD5 NOTCH2 ARHGAP33 ZNF574 PDZD2	7.75e-05	1498	155	24	ctd:C069837
Drug	3-methylsulfonyl-4-piperidinobenzoyl guanidine	SLC9A1 SLC9A2	1.38e-04	3	155	2	ctd:C074107
Drug	1,3-dioxoisoindoline-5-carboxamide	CACNA1I CACNA1H	1.38e-04	3	155	2	CID010679219
Drug	SureCN2398996	CACNA1I CACNA1H	1.38e-04	3	155	2	CID010220069
Drug	N-desmethylmethsuximide	CACNA1I CACNA1H	1.38e-04	3	155	2	CID000092154
Drug	5-N-(methyl-propyl)amiloride	SLC9A1 SLC9A2	1.38e-04	3	155	2	CID000193326
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A	PRR36 LAMA3 SFI1 TRIM3 CACNA1H MAPK7 NOVA2	1.51e-04	167	155	7	5212_UP
Drug	3,3',4,4',5,5'-hexabromobiphenyl	F8 GGT7 AHRR	2.34e-04	18	155	3	CID000104942
Drug	AC1L99OK	KCNH8 ELK1	2.74e-04	4	155	2	CID000415475
Drug	methsuximide	CACNA1I CACNA1H	2.74e-04	4	155	2	CID000006476
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; HL60; HT_HG-U133A	CRYBG2 ANK2 FOSL2 ARHGEF10 SIPA1L1 PPP1R37 MAPK7	3.11e-04	188	155	7	3046_UP
Drug	Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A	FOSL2 CARMIL1 TRIM3 SLC9A1 CELSR3 HOXD11 CACNA1I	3.21e-04	189	155	7	3084_UP
Drug	HCNs	TRIM3 CACNA1I CACNA1H	3.24e-04	20	155	3	CID006857665
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A	CRYBG2 IRF2BP1 TRIM3 MAP3K9 MAPK7 DMWD ARHGAP33	3.32e-04	190	155	7	4274_UP
Drug	Antimycin A [1397-94-0]; Down 200; 7.2uM; MCF7; HT_HG-U133A	KMT2B FOSL2 SKI CACNA1H ELK1 DGCR8 PGBD5	3.43e-04	191	155	7	2261_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	ZXDC PSKH1 DACH1 KDM6B GAS2L1 SLC9A1 DGCR8	3.43e-04	191	155	7	998_DN
Drug	Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A	DACH1 LAMA3 SETD2 SLC9A2 HOXD11 CACNA1I PGBD5	3.43e-04	191	155	7	6020_DN
Drug	17-AAG; Down 200; 1uM; HL60; HT_HG-U133A	ZXDC ACAP1 TEX2 KLF3 GAS2L1 ARHGEF10 ZNF76	3.43e-04	191	155	7	2685_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A	ZC3H14 ADAMTS1 CAMK1G SLC9A1 SLC25A12 SIPA1L1 SRRM2	3.54e-04	192	155	7	458_DN
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A	FOSL2 CC2D1A SFI1 SKI TRIM3 PRKAR1B ZNF574	3.65e-04	193	155	7	2209_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A	NUDT18 ZXDC KMT2B SFI1 TRIM3 DGCR8 SRRM2	3.65e-04	193	155	7	4322_UP
Drug	Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A	SEMA4D SFI1 SLC9A1 SIPA1L1 MAP3K9 PRKAR1B DGCR8	3.65e-04	193	155	7	5440_DN
Drug	Pyrithyldione [77-04-3]; Down 200; 24uM; PC3; HT_HG-U133A	ZXDC CC2D1A F8 NCOR1 PPP2R5B SRRM2 ZNF574	3.65e-04	193	155	7	7153_DN
Drug	dihydropyridine	AMPH ANK2 SLC9A1 CACNA1I CACNA1H REM2 NOS2	3.65e-04	193	155	7	CID000104822
Drug	Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	IRF2BP1 ARHGEF10 PRKAR1B CACNA1H ELK1 DGCR8 VAV2	3.76e-04	194	155	7	2828_UP
Drug	Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A	SPEG CC2D1A TBC1D17 PRKAR1B DGCR8 MAPK7 NOTCH2	3.76e-04	194	155	7	4838_UP
Drug	Tridihexethyl chloride; Up 200; 11.4uM; MCF7; HT_HG-U133A	NUDT18 PRR36 TRIM3 PRKAR1B DMWD SRRM2 ARHGAP33	3.76e-04	194	155	7	3526_UP
Drug	Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	IRF2BP1 KDM6B GAS2L1 SLC9A2 PRKAR1B PALM ZNF574	3.76e-04	194	155	7	4246_DN
Drug	Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; PC3; HT_HG-U133A	CRYBG2 KMT2B PRR36 FOSL2 TRIM3 PPP2R5B CACNA1I	3.76e-04	194	155	7	3676_UP
Drug	Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A	NUDT18 AMPH PRR36 OTUD7B CELSR3 CACNA1H SRRM2	3.76e-04	194	155	7	6835_UP
Drug	Loxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A	NUDT18 IRF2BP1 PSTPIP2 KDM6B CCDC88C MAPK7 ARHGAP33	3.76e-04	194	155	7	5293_UP
Drug	Diethylstilbestrol [56-53-1]; Up 200; 15uM; PC3; HT_HG-U133A	CRYBG2 TRIM3 LDB3 PRKAR1B CACNA1I VAV2 NOVA2	3.76e-04	194	155	7	3812_UP
Drug	Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; PC3; HG-U133A	FOSL2 NSD1 COL5A3 KDM6B FEZ2 DGCR8 NOTCH2	3.76e-04	194	155	7	1949_UP
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A	SEMA4D IRF2BP1 KDM6B GAS2L1 SLC9A2 AFF1 EPB41L1	3.76e-04	194	155	7	4242_DN
Drug	clofibrate; Up 200; 150uM; MCF7; HG-U133A	ACAP1 FOSL2 GAS2L1 PPP1R37 CACNA1I DMWD VAV2	3.76e-04	194	155	7	263_UP
Drug	Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A	IRF2BP1 LAMA3 KDM6B SETD2 SLC9A1 VAV2 PGBD5	3.88e-04	195	155	7	5388_DN
Drug	Acemetacin [53164-05-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	IRF2BP1 PRR36 BAHD1 SIPA1L1 DGCR8 MAPK7 DMWD	3.88e-04	195	155	7	5460_DN
Drug	Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A	KMT2B IRF2BP1 SKI SLC9A2 PALM SRRM2 EPB41L1	3.88e-04	195	155	7	3278_UP
Drug	LY 294002; Up 200; 10uM; HL60; HT_HG-U133A	IRF2BP1 TRIM3 SLC9A2 PPP2R5B SIPA1L1 ELK1 DGCR8	3.88e-04	195	155	7	2699_UP
Disease	Malignant neoplasm of breast	ACAP1 ANK2 ADAMTS1 PPM1D TNIP1 PANX2 BCAR1 TTC3 ECT2 FSCB NCOR1 SETD2 ZC3H11A SLC9A2 KMT2D HOXD11 SIPA1L1 ANKRD30A AFF1 NOS2 NOTCH2	2.57e-07	1074	156	21	C0006142
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	KMT2B SETD2 SRRM2	9.33e-05	17	156	3	DOID:0060307 (is_implicated_in)
Disease	Sotos' syndrome	NSD1 SETD2	1.65e-04	4	156	2	C0175695
Disease	nephrolithiasis (implicated_via_orthology)	SLC9A1 SLC9A2	2.75e-04	5	156	2	DOID:585 (implicated_via_orthology)
Disease	Malignant Cystosarcoma Phyllodes	SETD2 KMT2D	2.75e-04	5	156	2	C0600066
Disease	Phyllodes Tumor	SETD2 KMT2D	2.75e-04	5	156	2	C0010701
Disease	colon adenocarcinoma (is_marker_for)	FOSL2 PFAS NOS2	3.06e-04	25	156	3	DOID:234 (is_marker_for)
Disease	Myofibrillar myopathy	FLNC LDB3	4.11e-04	6	156	2	cv:C2678065
Disease	Mammary Carcinoma, Human	ADAMTS1 PPM1D TNIP1 NCOR1 SETD2 ZC3H11A KMT2D HOXD11 NOS2 NOTCH2	5.05e-04	525	156	10	C4704874
Disease	Mammary Neoplasms, Human	ADAMTS1 PPM1D TNIP1 NCOR1 SETD2 ZC3H11A KMT2D HOXD11 NOS2 NOTCH2	5.05e-04	525	156	10	C1257931
Disease	Mammary Neoplasms	ADAMTS1 PPM1D TNIP1 NCOR1 SETD2 ZC3H11A KMT2D HOXD11 NOS2 NOTCH2	5.20e-04	527	156	10	C1458155
Disease	Breast Carcinoma	ADAMTS1 PPM1D TNIP1 NCOR1 SETD2 ZC3H11A KMT2D HOXD11 NOS2 NOTCH2	6.10e-04	538	156	10	C0678222
Disease	eye color	CARMIL1 TTC3 SLC45A2 EFCAB7	1.35e-03	90	156	4	EFO_0003949
Disease	nevus count, cutaneous melanoma	NUDT18 SLC45A2 NOTCH2 SMIM44	1.41e-03	91	156	4	EFO_0000389, EFO_0004632
Disease	anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine	PHACTR2 MCM10	1.48e-03	11	156	2	EFO_0803358, EFO_0803362
Disease	platelet crit	NHSL2 CARMIL1 DACH1 ZC3H18 PSTPIP2 KDM6B SKI KRBA1 SLC9A2 CBX6 AFF1 ZNF76 SMIM44	1.70e-03	952	156	13	EFO_0007985
Disease	alpha fetoprotein measurement	SEMA4D NCOR1 AFF1 CCDC17	1.99e-03	100	156	4	EFO_0010583
Disease	Arthritis, Psoriatic	FBXL19 NOS2	2.42e-03	14	156	2	C0003872
Disease	diastolic blood pressure, systolic blood pressure	ACAP1 ANK2 SPEG CARMIL1 GPR135 ZC3H11B COL5A3 RBBP8NL AFAP1L2 AFF1	3.09e-03	670	156	10	EFO_0006335, EFO_0006336
Disease	Cardiovascular Abnormalities	ANKS6 NOS2	3.17e-03	16	156	2	C0243050
Disease	cutaneous psoriasis measurement, psoriasis	TNIP1 NOS2	3.17e-03	16	156	2	EFO_0000676, EFO_0007773
Disease	Psoriasis	TNIP1 FBXL19 NOS2	3.44e-03	57	156	3	C0033860
Disease	Pustulosis of Palms and Soles	TNIP1 FBXL19 NOS2	3.44e-03	57	156	3	C0030246
Disease	angina pectoris	PHACTR2 KCNH8 CARMIL1 BCAR1	4.44e-03	125	156	4	EFO_0003913
Disease	PR interval	CRYBG2 HDGFL1 CARMIL1 SKI LDB3 SIPA1L1 OTUD7A AFF1	4.97e-03	495	156	8	EFO_0004462

Protein segments in the cluster

Peptide	Gene	Start	Entry
PVPPPDKVDGFSRRS	PPP2R5B	21	Q15173
VTGRRETPGPTKPLP	AHRR	391	A9YTQ3
RTESEVPPRPASPKV	BARGIN	541	Q6ZT62
IKSPTIPRAERGNPP	CTTNBP2NL	566	Q9P2B4
TPRDSPRPGKPDERD	CTDP1	391	Q9Y5B0
PPPRTEEPLSGVKDR	CCDC17	591	Q96LX7
EEKRREPGAPPDPET	ARHGEF10	966	O15013
KAEPEVPPQEGVPAR	ELK1	271	P19419
KRAPPEVTAAAGPAP	CBX6	326	O95503
AVPPPAEREAPAEGK	BCAR1	411	P56945
KERTESEVPPRPASP	SH3BP1	531	Q9Y3L3
PPGASPPVKDRLRVT	AFAP1L2	636	Q8N4X5
RPTDGSSPDTPEKRP	APCDD1L	431	Q8NCL9
AAAVKVVPGPERPSP	ANKRD30A	6	Q9BXX3
PGPSAAAREPVVKLP	CLDN19	201	Q8N6F1
RPGSLRSKPEPPSED	ACAP1	551	Q15027
VLKSRGRPPTEPLPD	DGCR8	291	Q8WYQ5
PGRPPKRTQSVTSPE	DACH1	286	Q9UI36
GEKPSGPVPRSRLDP	DMWD	561	Q09019
APAPTFQPERPARKG	ANKRD33B	431	A6NCL7
DSGPLRIAKTPSPPE	AMPH	251	P49418
PPKRKEREAGNEPPT	FBXL19	211	Q6PCT2
EKTSVPTGLRLPPPD	NSD1	2376	Q96L73
ARRGPLPIPKSSPDD	PSTPIP2	306	Q9H939
SPVRAPAPSPAKEER	PALM	116	O75781
KVDESGPPAPSKPRR	PDS5A	1256	Q29RF7
ERLATAAPGEKPPAP	ADAMTS1	166	Q9UHI8
SRETDVSPFPPRKRP	ECT2	391	Q9H8V3
PPVSPGRTEKRLPVS	ANK2	1926	Q01484
TRGPRDKPTPPDELL	NOS2	126	P35228
PEKGFSDREPTRPPR	OTUD7B	66	Q6GQQ9
RVPPLRPETPKNGVS	FAM47C	386	Q5HY64
PKTRGSHLRPEPPET	FAM47C	431	Q5HY64
EPPKTRVSHLRPEPS	FAM47C	501	Q5HY64
PETGVSHLRPEPPKT	FAM47C	551	Q5HY64
SAPLEAPEPRKPVTA	MAPK7	496	Q13164
SRPPEGKHITTPREP	NOTCH2	2286	Q04721
DAPSPKPRLSPRETI	PALMD	361	Q9NP74
EKVKPPRPRAPESDT	EPB41L1	566	Q9H4G0
PGKRPLPVESPDTQR	KLF3	241	P57682
APDGIPERPKEPSSL	KRBA1	991	A5PL33
DGEPRPVAVRQPTPA	LAMA3	916	Q16787
SAPPAPRAEAEVRPK	JSRP1	186	Q96MG2
EGPAAPAPKPRVVTT	LDB3	386	O75112
VVPRPGAPLVTKESP	NCKAP5L	826	Q9HCH0
KRSAGDPPEDAPKRP	HDGFL1	146	Q5TGJ6
SAPAGEPPAPVRLRK	NUDT18	26	Q6ZVK8
PPLVEEATAKAEPRP	FSCB	271	Q5H9T9
VGLPPEPREKTISAP	PHKA1	856	P46020
ETEVPPPGPGRRTLK	FAM185A	51	Q8N0U4
ESPRPRVSFPKTPEV	KDM6B	626	O15054
TEPPSEPPRRARVAK	PSKH1	71	P11801
KRRAVESGVPQPPDP	BCCIP	6	Q9P287
PKAPPRSGEVATITP	CCDC88C	1941	Q9P219
PEDEPAPAAPLRGRK	GGT7	31	Q9UJ14
KTELEITPRRSPGPP	PDZD2	2511	O15018
FEVKREPSEGRPGPP	NRL	21	P54845
RPIPGSPFRVPVKDV	FLNC	1426	Q14315
SRDSKPPCRSVVPGP	PHRF1	651	Q9P1Y6
GELPVDARFPPRVPK	F8	41	P00451
PTPPKTPARKRGEEG	KMT2B	171	Q9UMN6
TKRVARTPKASPPDP	MCM10	186	Q7L590
AKRPPRRPETEGVPV	OTUD7A	691	Q8TE49
VPPPKPASRNTTREA	PHACTR2	206	O75167
PEPTAEEKPSPRRSL	PPM1D	31	O15297
PDSRKRPLETPPEVV	NOVA2	6	Q9UNW9
SSPPVVRPRPKSAEP	MAST1	1241	Q9Y2H9
SPGVRPEVENRPPET	CAMK1G	326	Q96NX5
VTRVESPPERAEPPA	PPP1R37	571	O75864
RPPPRFEDTGGPTRK	PGBD5	101	Q8N414
RPKPRAKEGTSDPPS	RBBP8NL	131	Q8NC74
EPTTPKAPASPAERR	ARHGAP33	561	O14559
REGPPEPVTAVTKQP	GPR135	471	Q8IZ08
TPRPKIVSPVSGPEH	ERVK-7	211	P61567
HIEGSPERDPSPVPK	EFCAB7	196	A8K855
EKPPPSPDITGRARQ	CEP89	216	Q96ST8
RSTKEGPETPPRPRD	GAS2L1	326	Q99501
AADRSKDPPGRAPLP	CACNA1I	2181	Q9P0X4
RRAGRPDPEPSEPSK	CRACD	991	Q6ZU35
PKPTPEAPISSADGR	LINC02875	136	Q86X59
PGQPPAPSTTRRKDV	CRYBG2	416	Q8N1P7
DLPEPERSPRPAAGK	ILKAP	6	Q9H0C8
PPAGRRPDVLFKAPE	HOXD11	131	P31277
KAPPVPAPARESGNR	CC2D1A	826	Q6P1N0
CKISPEERRSPPAPG	FOSL2	191	P15408
EVDGRSTEPPAPKAP	BAHD1	231	Q8TBE0
DTTPVRPVKFPSLPR	ANKS6	606	Q68DC2
RSSPRPGQPPKVKSE	CLDN2	206	P57739
VRKSTGPVPAPPDRA	DENND1A	551	Q8TEH3
EVSPTPPNPVVKARR	PRKAR1B	81	P31321
PPRSKATERPGQEPE	KNDC1	831	Q76NI1
EPSSPKGAVRSPPVD	CARMIL1	1091	Q5VZK9
APRESRTAPEPAPKR	CELSR3	261	Q9NYQ7
VRTAPPDGAAKRPPG	GPRIN1	971	Q7Z2K8
RVEPPGVPRSPVQDA	HES7	71	Q9BYE0
DPAEPGEKTPVRPVT	CACNA1H	2036	O95180
PGADRVVKAVPFPPT	PPP3CB	21	P16298
PFDSVEPPKRPTSRL	SLC45A2	21	Q9UMX9
PPSTRERPPGCKTVF	ENOX1	131	Q8TC92
ATVAPQGEPETPRPR	COL5A3	231	P25940
LKTPSPSRDPGEFPR	MAP3K9	946	P80192
PTPRRRKASPEPEGE	IRF2BP1	376	Q8IU81
DPGAEPPRTAVRPIT	FEZ2	66	Q9UHY8
DVPSGPPRKVEVEPL	PTPRF	706	P10586
PAEPDGAAEPPVVKR	PANX2	411	Q96RD6
VKARSGPPTIPSPLD	RTN1	386	Q16799
PIVVASPRGPLRKDP	MRPS5	381	P82675
SPRGPLRKDPEPEDE	MRPS5	386	P82675
VSAQRATPRDKPPVP	SFI1	1101	A8K8P3
SPTPAPKEAVREGRP	SRRM2	2581	Q9UQ35
RPESFTTPEGPKPRS	SLBP	56	Q14493
VAEKPPVARRPPSLV	NHSL2	871	Q5HYW2
ARPRPPTEGPRKSVS	PRR36	196	Q9H6K5
RESIPAKSPVPGVDP	NCOR1	1526	O75376
PSELRQPKPPHEGSR	SLC39A4	456	Q6P5W5
RRSGSPDVKGPPPVK	SATB2	16	Q9UPW6
TRSRDVPSFGPPIPK	SIPA1L1	756	O43166
APREEPLTPRLKPEG	INPPL1	951	O15357
PPVVPVSKPGALRRS	TCAP	141	O15273
PVPKPRPGACIDSEA	SEMA4D	361	Q92854
PTRRPPPSDKDCGRS	MESP1	21	Q9BRJ9
VKSPPEPRSEVVPAR	RIPK4	351	P57078
VPRVSSEPPASIRPK	SKI	321	P12755
RLKSVPADPAPPSRD	SSH1	831	Q8WYL5
TSAVEKEPARAPPEP	SERTAD3	156	Q9UJW9
GPRSTEPPRRHPESK	AFF1	531	P51825
APSLPRPERKSIVPA	ATF6B	296	Q99941
GSEPTPKSRIADLPP	SLC25A12	616	O75746
DVGLSKPAEPPAPAR	RNF223	161	E7ERA6
RPTEPESPKNDREGP	TNIP1	621	Q15025
SVIRSLKRPPPADAP	TNRC18	431	O15417
LKRPPPADAPTVRAT	TNRC18	436	O15417
PRPTVERGPPVTEEE	TBC1D17	271	Q9HA65
PSPERRSEVVGPFPL	nan	26	Q9BTK2
LAPIKVEPDSPSRPG	ZXDC	656	Q2QGD7
KDVRAPSRPAVGPPQ	ZSWIM9	81	Q86XI8
LKSPVPRSDIPEPER	THOC2	1391	Q8NI27
ERAGTPTPPVFQVRP	XKR7	491	Q5GH72
ADPPEARTKAPPGRK	SPEG	616	Q15772
EREDSLTEGIPPKPP	SLC9A2	776	Q9UBY0
PPRELESVPSKLGEP	SOGA3	146	Q5TF21
GEERAAKVPSTPPPK	SCAF1	966	Q9H7N4
EASEPPRVVRPEPST	ARHGAP23	461	Q9P227
KASVPREPGGPSPRV	PFAS	1051	O15067
APRSKGPRESVPPRD	ZSCAN1	351	Q8NBB4
PEPVPGPEKENVRTV	ZC3H11A	246	O75152
EVLAKEPPAPRAPRA	ZNF574	696	Q6ZN55
SERSPVADRKQPVPP	TTC3	1816	P53804
PPRERSIGDVTTAPP	SLC9A1	51	P19634
EPRRPSIAFKDPPSR	SMIM44	126	A0A286YF18
PEGPAPPARRESLTK	REM2	296	Q8IYK8
STGQQDPREKTPPRP	RNF185	96	Q96GF1
KSEGPPVPAPAERAR	TMEM275	6	A0A0U1RQS6
TPAPKTPNRSRERDP	SETD2	2051	Q9BYW2
EAPGVRPDPRPEKDA	nan	316	Q3C1V9
PEPVPGPEKENVRTV	ZC3H11B	246	A0A1B0GTU1
PEKPSRNPERELGDP	ZBTB32	131	Q9Y2Y4
GDTEKPEPERSPPNR	C9orf78	251	Q9NZ63
REPVASGEPPTVKEP	TXLNB	111	Q8N3L3
SVKPCPVDGRPPISR	VAV2	646	P52735
KEGHPVTSEPSRPEP	TST	136	Q16762
EDPKKPPRPQEGTRS	TEX2	666	Q8IWB9
VGVVPPRAKSPTPES	PLEKHA5	846	Q9HAU0
VRKSQEEAAPPSPRP	nan	61	Q6ZTI0
SVSVPAKPERRPSLP	ZC3H14	331	Q6PJT7
SAAEESPPPKRPRIA	ZNF76	391	P36508
PGDLPPSPDDVKRRV	TRIM3	421	O75382
VPEPTKPGDPREARR	ZC3H18	656	Q86VM9
PKPRARPPEEGEDSR	KMT2D	4961	O14686
RPPEEGEDSRPPRLK	KMT2D	4966	O14686
IRSEPRISPPLGDPE	KCNH8	836	Q96L42
PPKPERVTSLRSPGA	KIAA1522	551	Q9P206
EPPKSPPERAVLVSE	LRFN2	416	Q9ULH4